Evidence Hub

Therapeutic Mechanisms of Traditional Kampo Medicines in the Management of Mild COVID-19 through Gut Microbiota Modulation

Chiba S, Niwa Y, Furukata M, Morishita K, Shinohara K

Internal medicine (Tokyo, Japan), 2026

Abstract

Despite antiviral administration, a small number of patients still suffer from prolonged and severe COVID-19 owing to excessive inflammation. Traditional Kampo medicines (TKMs) with a heat-clearing effect have anti-inflammatory effects, such as a reduced NF-κB activity, and rarely cause serious side effects when administered for a short period of time. After oral administration, TKMs interact with the gut microbiota, producing two types of metabolites: metabolites from the gut microbiota (of food and host origin) and TKM compounds transformed by the gut microbiota. Both metabolites decreased the levels of pro-inflammatory cytokines. TKM compounds transformed by the gut microbiota may exhibit superior bioavailability compared with their precursors. In this review, we assessed the mechanism by which bioactive substances with anti-inflammatory effects, such as berberine, baicalin, saikosaponin, kaempferol, and short-chain fatty acids, are effective in treating respiratory symptoms after COVID-19 infection.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free